Sermorelin
Research compoundaka GHRH (1-29), Geref
GHRH analog that nudges your own pituitary to make GH. The gentle option.
Mechanism
The first 29 amino acids of GHRH, which is the active bit. It prompts your pituitary to release GH on its own schedule rather than forcing it. Short-acting, so timing matters.
Regulatory & Safety Status
Used to be approved (Geref), then pulled. These days you mostly get it through compounding pharmacies.
Research
Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Latest sermorelin research